NAMD

Clinical trials for NAMD explained in plain language.

Never miss a new study

Get alerted when new NAMD trials appear

Sign up with your email to follow new studies for NAMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1

Gene therapy could end frequent eye injections for wet AMD

Disease control Ongoing

This study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment aims to help the eye produce its own medicine to stop leaky blood vessels, potentially replacing the need for repeated eye injecti…

Matched conditions: NAMD

Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

NAMD

Get alerted when new NAMD trials appear

Gene therapy could end frequent eye injections for wet AMD